Boron Chemicals in Diagnosis and Therapeutics

  • Bhaskar C Das
    Division of Hematology & Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA
  • Pritam Thapa
    Division of Hematology & Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA
  • Radha Karki
    Division of Hematology & Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA
  • Caroline Schinke
    Albert Einstein College of Medicine, Bronx, NY, 10461, USA
  • Sasmita Das
    Division of Hematology & Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA
  • Suman Kambhampati
    Division of Hematology & Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA
  • Sushanta K Banerjee
    Division of Hematology & Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA
  • Peter Van Veldhuizen
    Division of Hematology & Oncology, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA
  • Amit Verma
    Albert Einstein College of Medicine, Bronx, NY, 10461, USA
  • Louis M Weiss
    Albert Einstein College of Medicine, Bronx, NY, 10461, USA
  • Todd Evans
    Department of Surgery, Weill Cornell Medical College of Cornell University, New York, NY, 10065, USA

書誌事項

公開日
2013-04
DOI
  • 10.4155/fmc.13.38
公開者
Informa UK Limited

この論文をさがす

収録刊行物

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ